{"id":"https://openalex.org/W2069665607","doi":"https://doi.org/10.1097/hjh.0b013e3282f2dac9","title":"Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats","display_name":"Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats","alternate_titles":[],"publication_year":2008,"publication_date":"2008-03-01","ids":{"openalex":"https://openalex.org/W2069665607","doi":"https://doi.org/10.1097/hjh.0b013e3282f2dac9","mag":"2069665607","pmid":"https://pubmed.ncbi.nlm.nih.gov/18300867"},"language":"en","primary_location":{"id":"doi:10.1097/hjh.0b013e3282f2dac9","doi":"https://doi.org/10.1097/hjh.0b013e3282f2dac9","is_oa":false,"landing_page_url":"https://doi.org/10.1097/hjh.0b013e3282f2dac9","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2069665607"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054300812","display_name":"Maxim Krikov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Maxim Krikov","raw_affiliation_strings":["Center for Cardiovascular Research (CCR), Institute of Pharmacology, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cardiovascular Research (CCR), Institute of Pharmacology, Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089238481","display_name":"Christa Th\u00f6ne\u2010Reineke","orcid":"https://orcid.org/0000-0003-0782-2755","observed_orcids":["https://orcid.org/0000-0003-0782-2755"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Christa Thone-Reineke","raw_affiliation_strings":["Center for Cardiovascular Research (CCR)/Institute of Pharmacology, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cardiovascular Research (CCR)/Institute of Pharmacology, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108345439","display_name":"Susanne M\u00fcller","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Susanne M\u00fcller","raw_affiliation_strings":["Clinic and Polyclinic for Neurology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Berlin, Germany","Krikov M, Schmerbach K, M\u00fcller S, Villringer A, Unger T and Th\u00f6ne-Reineke C. Pretreatment with candesartan \u2013 but not ramipril \u2013 induces neuroprotection following focal cerebral ischemia in rats and is associated with TrkB upregulation. Poster presentation, The 11th Annual Meeting of the European Council for Cardiovascular Research (ECCR), 2006, La Colle sur Loup, Nice, France","Previous presentations: Th\u00f6ne-Reineke C, Krikov M, Zimmermann M, Neumann C, Schmerbach K, Ungeth\u00fcm U, et al. Reduced expression of stress- and inflammation-related genes under candesartan pretreatment following transient focal ischemia in rats. Oral presentation, 16th European meeting on Hypertension, 2006, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinic and Polyclinic for Neurology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]},{"raw_affiliation_string":"Krikov M, Schmerbach K, M\u00fcller S, Villringer A, Unger T and Th\u00f6ne-Reineke C. Pretreatment with candesartan \u2013 but not ramipril \u2013 induces neuroprotection following focal cerebral ischemia in rats and is associated with TrkB upregulation. Poster presentation, The 11th Annual Meeting of the European Council for Cardiovascular Research (ECCR), 2006, La Colle sur Loup, Nice, France","institution_ids":[]},{"raw_affiliation_string":"Previous presentations: Th\u00f6ne-Reineke C, Krikov M, Zimmermann M, Neumann C, Schmerbach K, Ungeth\u00fcm U, et al. Reduced expression of stress- and inflammation-related genes under candesartan pretreatment following transient focal ischemia in rats. Oral presentation, 16th European meeting on Hypertension, 2006, Madrid, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020270555","display_name":"Arno Villringer","orcid":"https://orcid.org/0000-0003-2604-2404","observed_orcids":["https://orcid.org/0000-0003-2604-2404"]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Arno Villringer","raw_affiliation_strings":["Clinic and Polyclinic for Neurology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Berlin, Germany","Krikov M, Schmerbach K, M\u00fcller S, Villringer A, Unger T and Th\u00f6ne-Reineke C. Pretreatment with candesartan \u2013 but not ramipril \u2013 induces neuroprotection following focal cerebral ischemia in rats and is associated with TrkB upregulation. Poster presentation, The 11th Annual Meeting of the European Council for Cardiovascular Research (ECCR), 2006, La Colle sur Loup, Nice, France","Previous presentations: Th\u00f6ne-Reineke C, Krikov M, Zimmermann M, Neumann C, Schmerbach K, Ungeth\u00fcm U, et al. Reduced expression of stress- and inflammation-related genes under candesartan pretreatment following transient focal ischemia in rats. Oral presentation, 16th European meeting on Hypertension, 2006, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinic and Polyclinic for Neurology, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]},{"raw_affiliation_string":"Krikov M, Schmerbach K, M\u00fcller S, Villringer A, Unger T and Th\u00f6ne-Reineke C. Pretreatment with candesartan \u2013 but not ramipril \u2013 induces neuroprotection following focal cerebral ischemia in rats and is associated with TrkB upregulation. Poster presentation, The 11th Annual Meeting of the European Council for Cardiovascular Research (ECCR), 2006, La Colle sur Loup, Nice, France","institution_ids":[]},{"raw_affiliation_string":"Previous presentations: Th\u00f6ne-Reineke C, Krikov M, Zimmermann M, Neumann C, Schmerbach K, Ungeth\u00fcm U, et al. Reduced expression of stress- and inflammation-related genes under candesartan pretreatment following transient focal ischemia in rats. Oral presentation, 16th European meeting on Hypertension, 2006, Madrid, Spain","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052836637","display_name":"Thomas Unger","orcid":"https://orcid.org/0000-0002-0233-8705","observed_orcids":["https://orcid.org/0000-0002-0233-8705"]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas Unger","raw_affiliation_strings":["Center for Cardiovascular Research (CCR)/Institute of Pharmacology, Germany","to Thomas Unger, MD, Center for Cardiovascular Research (CCR)/Institut f\u00fcr Pharmakologie, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Hessische Strasse 3-4, 10115 Berlin, Germany Tel: +49 30 450 525 001; fax: +49 30 450 525 901; e-mail: [email\u00a0protected]","Krikov M, Schmerbach K, M\u00fcller S, Villringer A, Unger T and Th\u00f6ne-Reineke C. Pretreatment with candesartan \u2013 but not ramipril \u2013 induces neuroprotection following focal cerebral ischemia in rats and is associated with TrkB upregulation. Poster presentation, The 11th Annual Meeting of the European Council for Cardiovascular Research (ECCR), 2006, La Colle sur Loup, Nice, France","Previous presentations: Th\u00f6ne-Reineke C, Krikov M, Zimmermann M, Neumann C, Schmerbach K, Ungeth\u00fcm U, et al. Reduced expression of stress- and inflammation-related genes under candesartan pretreatment following transient focal ischemia in rats. Oral presentation, 16th European meeting on Hypertension, 2006, Madrid, Spain","e-mail: [email\u00a0protected]","fax: +49 30 450 525 901","to Thomas Unger, MD, Center for Cardiovascular Research (CCR)/Institut f\u00fcr Pharmakologie, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Hessische Strasse 3-4, 10115 Berlin, Germany Tel: +49 30 450 525 001"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Cardiovascular Research (CCR)/Institute of Pharmacology, Germany","institution_ids":[]},{"raw_affiliation_string":"to Thomas Unger, MD, Center for Cardiovascular Research (CCR)/Institut f\u00fcr Pharmakologie, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Hessische Strasse 3-4, 10115 Berlin, Germany Tel: +49 30 450 525 001; fax: +49 30 450 525 901; e-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I7877124"]},{"raw_affiliation_string":"Krikov M, Schmerbach K, M\u00fcller S, Villringer A, Unger T and Th\u00f6ne-Reineke C. Pretreatment with candesartan \u2013 but not ramipril \u2013 induces neuroprotection following focal cerebral ischemia in rats and is associated with TrkB upregulation. Poster presentation, The 11th Annual Meeting of the European Council for Cardiovascular Research (ECCR), 2006, La Colle sur Loup, Nice, France","institution_ids":[]},{"raw_affiliation_string":"Previous presentations: Th\u00f6ne-Reineke C, Krikov M, Zimmermann M, Neumann C, Schmerbach K, Ungeth\u00fcm U, et al. Reduced expression of stress- and inflammation-related genes under candesartan pretreatment following transient focal ischemia in rats. Oral presentation, 16th European meeting on Hypertension, 2006, Madrid, Spain","institution_ids":[]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +49 30 450 525 901","institution_ids":[]},{"raw_affiliation_string":"to Thomas Unger, MD, Center for Cardiovascular Research (CCR)/Institut f\u00fcr Pharmakologie, Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, Hessische Strasse 3-4, 10115 Berlin, Germany Tel: +49 30 450 525 001","institution_ids":["https://openalex.org/I7877124"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5054300812","https://openalex.org/A5089238481"],"corresponding_institution_ids":["https://openalex.org/I7877124"],"apc_list":null,"apc_paid":null,"fwci":8.2433,"has_fulltext":false,"cited_by_count":92,"citation_normalized_percentile":{"value":0.97884828,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"26","issue":"3","first_page":"544","last_page":"552"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.6909000277519226,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.6909000277519226,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.1339000016450882,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.12720000743865967,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/candesartan","display_name":"candesartan","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ramipril","display_name":"ramipril","score":1.0},{"id":"https://openalex.org/keywords/renin-angiotensin-system","display_name":"renin-angiotensin system","score":0.9419999718666077},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.7279999852180481},{"id":"https://openalex.org/keywords/focal-cerebral-ischemia","display_name":"focal cerebral ischemia","score":0.8429999947547913},{"id":"https://openalex.org/keywords/middle-cerebral-artery-occlusion","display_name":"middle cerebral artery occlusion","score":0.9359999895095825},{"id":"https://openalex.org/keywords/neurotrophins","display_name":"neurotrophins","score":0.9129999876022339},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.8190000057220459},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9309999942779541},{"id":"https://openalex.org/keywords/stroke-outcome","display_name":"stroke outcome","score":0.6209999918937683},{"id":"https://openalex.org/keywords/infarct-size","display_name":"infarct size","score":0.8669999837875366},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.6060000061988831}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9610077738761902},{"id":"https://openalex.org/C2780036600","wikidata":"https://www.wikidata.org/wiki/Q415970","display_name":"Candesartan","level":4,"score":0.9049105048179626},{"id":"https://openalex.org/C2779888176","wikidata":"https://www.wikidata.org/wiki/Q412666","display_name":"Ramipril","level":3,"score":0.8431798219680786},{"id":"https://openalex.org/C92020748","wikidata":"https://www.wikidata.org/wiki/Q420457","display_name":"Neurotrophin","level":3,"score":0.6963692307472229},{"id":"https://openalex.org/C97124661","wikidata":"https://www.wikidata.org/wiki/Q14897782","display_name":"Tropomyosin receptor kinase B","level":4,"score":0.643610417842865},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.5027012825012207},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.425589382648468},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37148618698120117},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3350718319416046},{"id":"https://openalex.org/C160539049","wikidata":"https://www.wikidata.org/wiki/Q3064187","display_name":"Neurotrophic factors","level":3,"score":0.27451393008232117},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.20346909761428833},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.13817796111106873},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001713","descriptor_name":"Biphenyl Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002545","descriptor_name":"Brain Ischemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017257","descriptor_name":"Ramipril","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019208","descriptor_name":"Brain-Derived Neurotrophic Factor","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":true},{"descriptor_ui":"D020133","descriptor_name":"Reverse Transcriptase Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D020813","descriptor_name":"Receptor, trkB","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1097/hjh.0b013e3282f2dac9","doi":"https://doi.org/10.1097/hjh.0b013e3282f2dac9","is_oa":false,"landing_page_url":"https://doi.org/10.1097/hjh.0b013e3282f2dac9","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"},{"id":"pmid:18300867","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18300867","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of hypertension","raw_type":"Comparative Study"},{"id":"pmh:oai:escidoc.org:escidoc:720619","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11858/00-001M-0000-0010-A30F-8","pdf_url":null,"source":{"id":"https://openalex.org/S7407052962","display_name":"Max Planck Digital Library","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210088280","host_organization_name":"Max Planck Digital Library","host_organization_lineage":["https://openalex.org/I4210088280"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.mpg.de:item_720619","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11858/00-001M-0000-0010-A30F-8","pdf_url":null,"source":{"id":"https://openalex.org/S4306400654","display_name":"MPG.PuRe (Max Planck Society)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I149899117","host_organization_name":"Max Planck Society","host_organization_lineage":["https://openalex.org/I149899117"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Hypertension","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320321526","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W43432051","https://openalex.org/W45000031","https://openalex.org/W1497461844","https://openalex.org/W1592471891","https://openalex.org/W1604542334","https://openalex.org/W1964325390","https://openalex.org/W1977906437","https://openalex.org/W1985716618","https://openalex.org/W1987561860","https://openalex.org/W1992230618","https://openalex.org/W1995316729","https://openalex.org/W2004469687","https://openalex.org/W2006759122","https://openalex.org/W2011903589","https://openalex.org/W2013900800","https://openalex.org/W2014871698","https://openalex.org/W2019823288","https://openalex.org/W2023719282","https://openalex.org/W2036369270","https://openalex.org/W2044447041","https://openalex.org/W2046794219","https://openalex.org/W2055505947","https://openalex.org/W2058850221","https://openalex.org/W2060266699","https://openalex.org/W2063616597","https://openalex.org/W2064262196","https://openalex.org/W2070283725","https://openalex.org/W2091746603","https://openalex.org/W2098429613","https://openalex.org/W2101717161","https://openalex.org/W2106501423","https://openalex.org/W2133217116","https://openalex.org/W2146798390","https://openalex.org/W2158892872","https://openalex.org/W2160654062","https://openalex.org/W2166346391","https://openalex.org/W2269564791","https://openalex.org/W2313553121","https://openalex.org/W2562329777","https://openalex.org/W4301776978"],"related_works":["https://openalex.org/W2080717604","https://openalex.org/W2006922743","https://openalex.org/W2730612458","https://openalex.org/W2121991673","https://openalex.org/W2045949754","https://openalex.org/W2036710375","https://openalex.org/W2150636419","https://openalex.org/W2089366761"],"abstract_inverted_index":{"OBJECTIVES:":[0],"Drugs":[1],"interfering":[2],"with":[3,40,60,100,133,174,222,230,243],"the":[4,13,41,47,64,212,247],"renin-angiotensin":[5],"system":[6],"(RAS)":[7],"have":[8],"been":[9],"shown":[10],"to":[11,22,32,83,127],"reduce":[12,182],"incidence":[14],"of":[15,37,66,72,80,136,161,211,235,246],"stroke":[16,137,201],"in":[17,25,52,163,219],"patients":[18],"at":[19,196,252],"risk":[20],"and":[21,46,74,110,151,176,203,209,254],"afford":[23],"neuroprotection":[24,238],"experimental":[26],"brain":[27,164],"ischemia.":[28],"This":[29],"study":[30],"aimed":[31],"compare":[33],"potential":[34],"neuroprotective":[35,261],"effects":[36],"systemic":[38],"pretreatment":[39,229],"angiotensin":[42,86,91],"receptor":[43],"blocker,":[44],"candesartan,":[45,223],"angiotensin-converting":[48],"enzyme":[49],"(ACE)-inhibitor,":[50],"ramipril,":[51],"normotensive":[53],"Wistar":[54],"rats":[55],"after":[56,149,158,170,239],"focal":[57,240],"cerebral":[58,129],"ischemia,":[59,241],"special":[61],"emphasis":[62],"on":[63],"regulation":[65],"neurotrophins.":[67],"METHODS:":[68],"Equipotent":[69],"subcutaneous":[70],"doses":[71,257],"candesartan":[73,101,175,236],"ramipril":[75,108,177,188,195],"were":[76,98,166,216],"determined":[77],"via":[78,140],"inhibition":[79],"pressor":[81],"responses":[82],"intravenously":[84],"injected":[85],"II":[87],"(Ang":[88,93],"II)":[89],"or":[90,117],"I":[92],"I),":[94],"respectively.":[95],"Accordingly,":[96],"animals":[97,220],"treated":[99,221],"(0.1":[102],"mg/kg":[103,112],"body":[104,113],"weight,":[105,114],"twice":[106,115,121],"daily),":[107,122],"(0.01":[109],"0.1":[111],"daily)":[116],"vehicle":[118],"(0.9%":[119],"saline,":[120],"respectively,":[123],"5":[124],"days":[125],"prior":[126],"middle":[128],"artery":[130],"occlusion":[131],"(MCAO)":[132],"reperfusion.":[134],"Severity":[135],"was":[138],"estimated":[139],"infarct":[141],"size":[142],"[magnetic":[143],"resonance":[144],"imaging":[145],"(MRI)":[146],"48":[147,156,168],"h":[148,157,169],"MCAO]":[150],"neurological":[152,205],"outcome":[153],"(24":[154],"h,":[155],"MCAO).":[159],"Measurements":[160],"neurotrophins/receptors":[162],"tissue":[165],"performed":[167],"MCAO.":[171],"RESULTS:":[172],"Pretreatment":[173],"(low":[178],"dose)":[179],"did":[180],"not":[181,194,225],"blood":[183],"pressure":[184],"during":[185],"MCAO,":[186],"whereas":[187],"high":[189],"dose":[190,234],"did.":[191],"Candesartan,":[192],"but":[193,224],"any":[197],"dose,":[198],"significantly":[199,217],"reduced":[200],"volume":[202],"improved":[204],"outcome.":[206],"Poststroke":[207],"mRNA":[208],"protein":[210],"neurotrophin":[213,248],"receptor,":[214],"TrkB,":[215],"elevated":[218],"ramipril.":[226],"CONCLUSIONS:":[227],"Systemic":[228],"a":[231],"sub-hypotensive,":[232],"RAS-blocking":[233,256],"affords":[237],"associated":[242],"increased":[244],"activity":[245],"BDNF/TrkB":[249],"system.":[250],"Ramipril":[251],"sub-hypotensive":[253],"hypotensive,":[255],"showed":[258],"no":[259],"significant":[260],"effects.":[262]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2069665607","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
